Live Breaking News & Updates on Travis Mickle|Page 2

Stay updated with breaking news from Travis mickle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KemPharm receives Orphan Drug Designation for prodrug

KemPharm has received the Orphan Drug Designation from the US FDA for serdexmethylphenidate to treat idiopathic hypersomnia. ....

Travis Mickle , Orphan Drug Designation ,

Serdexmethylphenidate Gets Orphan Drug Status for Idiopathic Hypersomnia

The FDA has granted Orphan Drug designation to serdexmethylphenidate (KP1077) for the treatment of idiopathic hypersomnia. ....

Travis Mickle , Drug Administration , Orphan Drug ,

KemPharm Receives FDA Orphan Drug Designation for Serdexmethylphenidate (SDX) for the Treatment of Idiopathic Hypersomnia (IH)

18.11.2022 - Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022 CELEBRATION, Fla., Nov. 18, 2022 (GLOBE NEWSWIRE) - KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a biotechnology company . Seite 1 ....

United States , Travis Mickle , Orphan Drug Designation , Chief Executive Officer , Drug Designation ,

KemPharm's Phase I Cardiovascular Safety Study Of Serdexmethylphenidate Yields Positive Results

(RTTNews) - Florida-based KemPharm Inc. (KMPH) has announced positive top-line data from an exploratory phase I trial evaluating the cardiovascula. ....

Travis Mickle , Kempharm Inc , Novarti Ritalin , Chief Executive Officer ,

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)

KemPharm Announces Positive Topline Data from Phase 1 Clinical Trial Evaluating Cardiovascular Safety of Serdexmethylphenidate (SDX)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Travis Mickle , Company Early Access Program , Corium Inc , Drug Administration , Exchange Commission , Kempharm Inc , Wall Street , Chief Executive Officer , Early Access Program , Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Pharm Contacts , Strategic Advisors , Inc Jason , Daniel Kontoh Boateng ,